Prostate cancer is the second most common and deadly cancer among American men. About 1 in 6 men will be diagnosed with prostate cancer during their lifetime, and about 1 in 33 men will die from the disease. Yet, despite the disease’s potential dangers, many men diagnosed with prostate cancer shouldn’t be treated aggressively, and others shouldn’t be treated at all (but still be closely monitored). This is why Dr. Anthony D’Amico, Chief of the Prostate Cancer Radiation Oncology Service at Dana-Farber/Brigham and Women’s Cancer Center, says that determining a prostate cancer patient’s risk level is critical to determining their treatment. Watch the video below to learn more.
Please visit our Prostate Cancer Education Center to learn more about this disease, which is estimated to currently affect more than two million American men.- Chris P.